Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,589,346
  • Shares Outstanding, K 95,520
  • Annual Sales, $ 1,243 M
  • Annual Income, $ -535,980 K
  • EBIT $ 84 M
  • EBITDA $ 82 M
  • 60-Month Beta 0.81
  • Price/Sales 8.19
  • Price/Cash Flow N/A
  • Price/Book 8.33

Options Overview Details

View History
  • Implied Volatility 41.01% ( -1.53%)
  • Historical Volatility 34.19%
  • IV Percentile 18%
  • IV Rank 5.88%
  • IV High 147.45% on 05/29/24
  • IV Low 34.36% on 08/20/24
  • Put/Call Vol Ratio 0.85
  • Today's Volume 1,452
  • Volume Avg (30-Day) 1,744
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 45,112
  • Open Int (30-Day) 46,889

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.33
  • Number of Estimates 8
  • High Estimate 1.68
  • Low Estimate 0.80
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +182.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.15 +8.17%
on 11/18/24
133.36 -17.14%
on 10/25/24
-16.81 (-13.20%)
since 10/21/24
3-Month
102.15 +8.17%
on 11/18/24
144.22 -23.38%
on 08/22/24
-32.95 (-22.97%)
since 08/21/24
52-Week
78.67 +40.46%
on 12/01/23
173.25 -36.22%
on 06/21/24
+26.42 (+31.42%)
since 11/21/23

Most Recent Stories

More News
Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript

SRPT earnings call for the period ending September 30, 2024.

SRPT : 110.50 (-0.32%)
Sarepta Therapeutics: Q3 Earnings Snapshot

Sarepta Therapeutics: Q3 Earnings Snapshot

SRPT : 110.50 (-0.32%)
2 High-Flying Growth Stocks With Massive Upside Potential

These innovative drugmakers have potential catalysts ahead.

SRPT : 110.50 (-0.32%)
LLY : 749.92 (-0.46%)
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

These two could become direct competitors relatively soon.

SRPT : 110.50 (-0.32%)
WVE : 14.35 (+0.63%)
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy

SRPT : 110.50 (-0.32%)
PEPG : 4.32 (-1.82%)
CAPR : 17.79 (-5.97%)
Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options

Investors in Sarepta Therapeutics, Inc. SRPT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $80 Call had some of the highest implied...

SRPT : 110.50 (-0.32%)
These 2 Biotech Stocks Are Set to Soar

Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins.

VKTX : 51.63 (+0.19%)
SRPT : 110.50 (-0.32%)
2 Biotech Stocks to Buy Hand Over Fist in August

Both of these biotechs are highly innovative companies.

VRTX : 450.37 (-0.19%)
SRPT : 110.50 (-0.32%)
Stocks Rally Sharply on Positive US Labor Market News

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +2.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.06%. US stocks on Thursday...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-180 (+0.06%)
ARM : 133.14 (-0.42%)
ON : 68.47 (+1.72%)
MRVL : 92.94 (+3.43%)
INTC : 24.44 (+1.79%)
KLAC : 633.16 (+2.65%)
Stocks Rally as Economic Concerns Ease and Chip Stocks Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.24%. US stocks are trading higher today...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-180 (+0.06%)
ON : 68.47 (+1.72%)
AMAT : 175.75 (+3.09%)
MRVL : 92.94 (+3.43%)
ARM : 133.14 (-0.42%)
MCHP : 66.51 (+2.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 114.59
2nd Resistance Point 113.19
1st Resistance Point 111.84
Last Price 110.50
1st Support Level 109.09
2nd Support Level 107.69
3rd Support Level 106.34

See More

52-Week High 173.25
Fibonacci 61.8% 137.12
Fibonacci 50% 125.96
Fibonacci 38.2% 114.80
Last Price 110.50
52-Week Low 78.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar